I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.
Climate Compass on MSN
Chile is becoming a leader in solar energy development
Few stories in the global clean energy world are as quietly remarkable as what is happening right now in Chile. A long, narrow country tucked against the Pacific coast of South America, Chile has ...
NEW YORK, NY, UNITED STATES, April 10, 2026 /EINPresswire.com/ -- Cronus Capital Management LLC, a premier financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results